Celemics, Inc. Stock

Equities

A331920

KR7331920009

Biotechnology & Medical Research

End-of-day quote Korea S.E. 18:00:00 2024-04-25 EDT 5-day change 1st Jan Change
3,645 KRW +1.67% Intraday chart for Celemics, Inc. -1.75% -13.83%

Financials

Sales 2022 8.73B 6.35M 8.67M Sales 2023 6.58B 4.78M 6.53M Capitalization 34.53B 25.11M 34.29M
Net income 2022 -4.8B -3.49M -4.76M Net income 2023 -3.88B -2.82M -3.85M EV / Sales 2022 4.09 x
Net cash position 2022 11.61B 8.44M 11.53M Net cash position 2023 9.83B 7.15M 9.76M EV / Sales 2023 3.76 x
P/E ratio 2022
-9.86 x
P/E ratio 2023
-8.91 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 83.75%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.67%
1 week-1.75%
Current month-24.14%
1 month-26.66%
3 months-13.32%
6 months+18.73%
Current year-13.83%
More quotes
1 week
3 550.00
Extreme 3550
3 800.00
1 month
3 550.00
Extreme 3550
5 060.00
Current year
3 550.00
Extreme 3550
5 800.00
1 year
2 745.00
Extreme 2745
5 800.00
3 years
2 745.00
Extreme 2745
22 350.00
5 years
2 745.00
Extreme 2745
39 400.00
10 years
2 745.00
Extreme 2745
39 400.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Chief Executive Officer 59 -
More insiders
Date Price Change Volume
24-04-26 3,645 +1.67% 4,497
24-04-25 3,585 -1.38% 8,680
24-04-24 3,635 -0.27% 8,171
24-04-23 3,645 -1.22% 4,573
24-04-22 3,690 -0.54% 5,794

End-of-day quote Korea S.E., April 25, 2024

More quotes
Celemics Inc is a Korea-based company mainly engaged in manufacturing products related to life science medicine. The Company mainly develops and sells target capture kit products. In addition, the Company is engaged in immune repertoire analysis solutions and next-generation sequencing solutions. The Company sells its products in domestic and overseas markets.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A331920 Stock